Skip to main content

Day: September 14, 2021

Firan Technology Group Corporation (“FTG”) is Awarded $3.7 Million (CAD) After-Market Contract by Defense Logistics Agency (DLA) for Electronic Assemblies to Support Airborne Radar Systems

TORONTO, Sept. 14, 2021 (GLOBE NEWSWIRE) — Firan Technology Group Corporation (TSX:FTG) has been awarded a $3.7M CAD after-market contract from the United States Defense Logistics Agency (DLA) to provide electronic assemblies to retrofit airborne radar systems on various US Armed Forces aircraft. The work will be performed at the FTG facilities in Chatsworth, California. “We are pleased to receive this significant award. We are committed to the DLA’s mission to support and extend the service life of military aircraft,” said Brad Bourne, FTG’s President and CEO. “We are excited about the direction of our after-market initiative providing the DLA various products including these high quality, high reliability complex electronic assemblies.” The award is a long-term after-market contract that enables multiple product draws, and ensures...

Continue reading

Guggenheim Investments Announces Shareholder Approval of the Mergers of GPM, GGM and GOF

NEW YORK, Sept. 14, 2021 (GLOBE NEWSWIRE) — Guggenheim Investments announced today that shareholders approved the mergers (each, a “Merger” and together, the “Mergers”) of Guggenheim Enhanced Equity Income Fund (NYSE: GPM) and Guggenheim Credit Allocation Fund (NYSE: GGM) with and into Guggenheim Strategic Opportunities Fund (NYSE: GOF), each a closed-end fund (each, a “Fund” and together, the “Funds”). Subject to the satisfaction of certain customary closing conditions, the Mergers are expected to be effective with the open of the New York Stock Exchange on October 25, 2021.Acquired Funds Ticker Acquiring Fund TickerGuggenheim Enhanced Equity Income Fund GPM Guggenheim Strategic Opportunities Fund GOFGuggenheim Credit Allocation Fund GGMAt the joint special meeting of shareholders (the “Special Meeting”) held on August...

Continue reading

First Light Acquisition Group, Inc. Completes $230 Million Initial Public Offering

NEW YORK, Sept. 14, 2021 (GLOBE NEWSWIRE) — First Light Acquisition Group, Inc. (the “Company”), a blank check company formed for the purpose of entering into a combination with one or more businesses or entities, announced today the closing of its initial public offering of 23,000,000 units, which includes 3,000,000 units issued pursuant to the full exercise by the underwriter of its over-allotment option, at a price of $10.00 per unit. The units have been listed on the New York Stock Exchange (“NYSE”) and have started trading under the ticker symbol “FLAGU.” Each unit issued in the offering consists of one share of the Company’s Class A common stock and one-half of one redeemable warrant of the Company. Each whole warrant entitles the holder thereof to purchase one share of the Company’s Class A common stock at a price of $11.50...

Continue reading

Allarity Therapeutics Receives Approximately SEK 16.5 Million (US $1.9 Million) from Subscription to Warrants of Series ALLR TO 3

 Subscription is approximately 6.7 percent of total outstanding TO 3 warrants Allarity’s Chairman of the Board and largest shareholder (Sass & Larsen ApS) participated in the subscriptionPress Release Hørsholm, Denmark (September 14, 2021) – Allarity Therapeutics A/S (“Allarity” or the “Company”) today announces the outcome of the exercise of the warrants of series ALLR TO 3 that were issued in connection with the Company’s issue of units in June 2021. In total, 9,719,266 warrants of series TO 3 were exercised, corresponding to approximately 6.7 percent of the total number of outstanding warrants, for subscription of 9,719,266 shares at a subscription price of SEK 1.7 per share. Through the exercise of the warrants, Allarity will receive approximately SEK 16.5 million (U.S. $1.9 million) before issuing costs amounting to approximately...

Continue reading

Onex Partners and BPEA Complete Offering of Clarivate Shares

All amounts in U.S. dollars unless otherwise stated TORONTO and HONG KONG, Sept. 14, 2021 (GLOBE NEWSWIRE) — Onex Corporation (“Onex”) (TSX: ONEX), Baring Private Equity Asia (“BPEA”) and their affiliated funds (together the “Group”), today announced they have sold 25 million ordinary shares of Clarivate plc (“Clarivate”) (NYSE: CLVT) at a price of $25.25 per share. In addition, the underwriters were granted a 30-day option to purchase up to 3.75 million ordinary shares from the Group. Clarivate is a global leader in providing trusted information and insights to accelerate the pace of innovation. At the purchase price and before the underwriters’ option, net proceeds to the Group were approximately $630 million, of which Onex’ share was approximately $120 million as a Limited Partner in Onex Partners IV and as a co-investor. The...

Continue reading

AMREP Reports First Quarter Fiscal 2022 Results

HAVERTOWN, Pa., Sept. 14, 2021 (GLOBE NEWSWIRE) — AMREP Corporation (NYSE:AXR) today reported net income of $1,637,000, or $0.22 per diluted share, for its 2022 fiscal first quarter ended July 31, 2021 compared to net income of $593,000, or $0.07 per diluted share, for the same period of the prior year.   Revenues were $10,507,000 for the first quarter of 2022 and $4,206,000 for the first quarter of 2021. More information about the Company’s financial performance for the first quarters of 2022 and 2021 may be found in AMREP Corporation’s financial statements on Form 10-Q which have today been filed with the Securities and Exchange Commission and will be available on AMREP’s website (www.amrepcorp.com/sec-filings/). AMREP Corporation, through its subsidiaries, is a major holder of land, leading developer of real estate and award-winning...

Continue reading

Altus Group Announces C$150 Million Bought Deal Financing

NOT FOR DISTRIBUTION TO U.S. NEWS WIRE SERVICES OR DISSEMINATION IN THE UNITED STATES TORONTO, Sept. 14, 2021 (GLOBE NEWSWIRE) — Altus Group Limited (“Altus Group” or the “Company”) (TSX: AIF), a leading provider of software, data solutions and independent advisory services to the global commercial real estate industry, announced today that it has entered into an agreement with a syndicate of underwriters (the “Underwriters”) led by bookrunners TD Securities Inc. and BMO Capital Markets, under which the Underwriters have agreed to buy on a bought deal basis 2,420,000 common shares in the capital of the Company (the “Common Shares”), at a price of $62.00 per Common Share (the “Offering Price”) for gross proceeds of approximately $150 million (the “Offering”). The Company has granted the Underwriters an option, exercisable at the...

Continue reading

Verizon to offer all-new iPhone 13 lineup, iPad and iPad mini with orders starting 9/17

Current and new Verizon customers can get an iPhone 13 on us with select trade-in on select Unlimited plans1 BASKING RIDGE, N.J., Sept. 14, 2021 (GLOBE NEWSWIRE) — Verizon will offer the best-ever lineup of iPhone and iPad, including the innovative and elegant iPhone 13 Pro, iPhone 13 Pro Max, iPhone 13, and iPhone 13 mini, the highly capable and affordable iPad (9th generation) and iPad mini with a new all-screen design. Redesigned inside and out, iPhone 13 Pro and iPhone 13 Pro Max introduce the most advanced pro camera system ever on iPhone, Super Retina XDR display with ProMotion, improved battery life, the Apple-designed A15 Bionic chip with 5-core GPU and an advanced 5G experience. iPhone 13 and iPhone 13 mini feature the most advanced dual camera system ever in iPhone and the powerhouse A15 Bionic chip in a sleek and durable...

Continue reading

Checkmate Pharmaceuticals to Present at the Cantor Virtual Global Healthcare Conference

CAMBRIDGE, Mass., Sept. 14, 2021 (GLOBE NEWSWIRE) — Checkmate Pharmaceuticals Inc. (NASDAQ: CMPI) (“Checkmate”), a clinical stage biopharmaceutical company focused on developing its proprietary technology to harness the power of the immune system to combat cancer, today announced that Barry Labinger, CEO, will present at the Cantor Virtual Global Healthcare Conference on Thursday, September 30 from 10:40-11:10am ET. Checkmate will also host 1×1 investor meetings during the conference. The webcast can be accessed under “Events & Presentations” in the Investors section of the Checkmate website. An archived copy of the webcast will be available on the Checkmate website for approximately 90 days after the event. About Checkmate Pharmaceuticals Checkmate Pharmaceuticals is a clinical stage biotechnology company focused on...

Continue reading

Travere Therapeutics Appoints Ruth Williams-Brinkley to its Board of Directors

Ms. Williams-Brinkley brings more than 35 years of executive leadership experience in healthcare to the Travere Board SAN DIEGO, Sept. 14, 2021 (GLOBE NEWSWIRE) — Travere Therapeutics, Inc. (NASDAQ: TVTX) today announced the appointment of Ruth Williams-Brinkley to the Company’s Board of Directors, effective immediately. Ms. Williams-Brinkley brings to Travere more than 35 years of executive leadership in care delivery and health plan operations. “On behalf of the Board of Directors, I am pleased to welcome Ruth to Travere,” said Gary Lyons, chairman of the Travere Therapeutics Board of Directors. “She is a distinguished leader with extensive experience in the delivery of care and is an actively engaged and admired community leader. As we look to future potential commercial launches from our pipeline, Ruth’s insights will be instrumental...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.